,paragraph,value,label,name,type,company,sent,entity,entity_type_ext,sentence,phrases,qa_temp,key,score,question,answer,GPT3 Responses
0,"As of February 12, 2021, there were 145.9 million shares (excluding 49.2 million shares held in treasury) of the registrant's common stock outstanding. The aggregate market value of the common stock held by non affiliates of the registrant as of June 28, 2020 (the last business day of the registrant's most recently completed second fiscal quarter), based on the closing price for the common stock on The NASDAQ Global Select Market on June 26, 2020 (the last trading day before June 28, 2020), was $46.2 billion. This amount excludes an aggregate of approximately 18.1 million shares of common stock held by officers and directors and each person known by the registrant to own 10% or more of the outstanding common stock. Exclusion of shares held by any person should not be construed to indicate that such person possesses the power, directly or indirectly, to direct or cause the direction of the management or policies of the registrant, or that the registrant is controlled by or under common control with such person.",145.9,"['Entity Common Stock, Shares Outstanding']",dei_EntityCommonStockSharesOutstanding,sharesItemType,ilmn,"As of February 12, 2021, there were 145.9 million shares (excluding 49.2 million shares held in treasury) of the registrant’s common stock outstanding.",145.9 million,CARDINAL,"As of February 12, 2021, there were 145.9 million shares excluding 49.2 million shares held in treasury of the registrant’s common stock outstanding.",['registrant common outstanding stock'],"['shares', 0.8369184732437134, 'What is 145.9 million ?', 'shares']",shares,0.8369184732437134,What is 145.9 million ?,shares,Shares of common stock outstanding
1,"As of February 12, 2021, there were 145.9 million shares (excluding 49.2 million shares held in treasury) of the registrant's common stock outstanding. The aggregate market value of the common stock held by non affiliates of the registrant as of June 28, 2020 (the last business day of the registrant's most recently completed second fiscal quarter), based on the closing price for the common stock on The NASDAQ Global Select Market on June 26, 2020 (the last trading day before June 28, 2020), was $46.2 billion. This amount excludes an aggregate of approximately 18.1 million shares of common stock held by officers and directors and each person known by the registrant to own 10% or more of the outstanding common stock. Exclusion of shares held by any person should not be construed to indicate that such person possesses the power, directly or indirectly, to direct or cause the direction of the management or policies of the registrant, or that the registrant is controlled by or under common control with such person.",46.2,['Entity Public Float'],dei_EntityPublicFloat,monetaryItemType,ilmn,"The aggregate market value of the common stock held by non affiliates of the registrant as of June 28, 2020 (the last business day of the registrant’s most recently completed second fiscal quarter), based on the closing price for the common stock on The NASDAQ Global Select Market on June 26, 2020 (the last trading day before June 28, 2020), was $46.2 billion.",$46.2 billion,MONEY,"The aggregate market value of the common stock held by non affiliates of the registrant as of June 28, 2020 , based on the closing price for the common stock on The NASDAQ Global Select Market on June 26, 2020 the last trading day before June 28, 2020, was $46.2 billion.","['aggregate market value of common stock', 'non affiliates of registrant', 'closing price for common stock', 'common stock on NASDAQ Global Select Market', 'closing price on June', 'last trading day before June', 'aggregate market value', 'common stock', 'non affiliates', 'closing price', 'common stock', 'NASDAQ Global Select Market']","['closing price on June', 0.9166859984397888, 'what is closing price on June ?', '$46.2 billion']",closing price on June,0.9166859984397888,what is closing price on June ?,$46.2 billion,Aggregate market value of common stock held by non affiliates
2,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",10,"['Preferred stock, shares authorized']",us-gaap_PreferredStockSharesAuthorized,sharesItemType,ilmn,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",10 million,CARDINAL,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",[],"['shares authorized', 0.982784628868103, 'What is 10 million ?', 'shares authorized']",shares authorized,0.982784628868103,What is 10 million ?,shares authorized,Preferred stock shares authorized
3,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",10,"['Preferred stock, shares authorized']",us-gaap_PreferredStockSharesAuthorized,sharesItemType,ilmn,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",10 million,CARDINAL,"Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at January 3, 2021 and December 29, 2019",[],"['shares authorized', 0.982784628868103, 'What is 10 million ?', 'shares authorized']",shares authorized,0.982784628868103,What is 10 million ?,shares authorized,Preferred stock authorized
4,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",320,"['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",320 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['shares authorized', 0.9675116539001465, 'What is 320 million ?', 'shares authorized']",shares authorized,0.9675116539001464,What is 320 million ?,shares authorized,Common stock shares authorized
5,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",320,"['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",320 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['shares authorized', 0.9675116539001465, 'What is 320 million ?', 'shares authorized']",shares authorized,0.9675116539001464,What is 320 million ?,shares authorized,common stock shares authorized
6,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",195,"['Common stock, shares issued']",us-gaap_CommonStockSharesIssued,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",195 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['shares issued', 0.8388774394989014, 'What is 195 million ?', 'shares issued']",shares issued,0.8388774394989014,What is 195 million ?,shares issued,common stock shares authorized
7,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",146,"['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",146 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['outstanding', 0.858413577079773, 'What is 146 million ?', 'outstanding']",outstanding,0.858413577079773,What is 146 million ?,outstanding,shares outstanding
8,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",194,"['Common stock, shares issued']",us-gaap_CommonStockSharesIssued,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",194 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['shares issued', 0.9204299449920654, 'What is 194 million ?', 'shares issued']",shares issued,0.9204299449920654,What is 194 million ?,shares issued,shares issued
9,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",147,"['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,ilmn,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019",147 million,CARDINAL,"Common stock, $0.01 par value, 320 million shares authorized; 195 million shares issued and 146 million outstanding at January 3, 2021; 194 million shares issued and 147 million outstanding at December 29, 2019","['Common stock at January', 'Common stock at December']","['outstanding', 0.5889466404914856, 'What is 147 million ?', 'outstanding']",outstanding,0.5889466404914856,What is 147 million ?,outstanding,Common stock shares outstanding
10,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively",49,"['Treasury stock, shares']",us-gaap_TreasuryStockShares,sharesItemType,ilmn,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively",49 million,CARDINAL,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively","['shares at cost', 'Treasury stock at January']","['shares', 0.664198100566864, 'What is 49 million ?', 'shares']",shares,0.664198100566864,What is 49 million ?,shares,"Treasury stock at January 3, 2021"
11,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively",47,"['Treasury stock, shares']",us-gaap_TreasuryStockShares,sharesItemType,ilmn,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively",47 million,CARDINAL,"Treasury stock, 49 million shares and 47 million shares at cost at January 3, 2021 and December 29, 2019, respectively","['shares at cost', 'Treasury stock at January']","['shares at cost', 0.9100867509841919, 'how many shares at cost ?', '47 million']",shares at cost,0.910086750984192,how many shares at cost ?,47 million,"Treasury stock at December 29, 2019"
12,"International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively. Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",49,['Concentration percent'],us-gaap_ConcentrationRiskPercentage1,percentItemType,ilmn,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.",49%,PERCENT,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.","['Shipments to customers', 'customers outside United States', '% of total revenue', 'total revenue']","['Shipments', 0.9291008114814758, 'What is 49% ?', 'Shipments']",Shipments,0.9291008114814758,What is 49% ?,Shipments,Shipments to customers outside the United States
13,"International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively. Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",48,['Concentration percent'],us-gaap_ConcentrationRiskPercentage1,percentItemType,ilmn,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.",48%,PERCENT,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.","['Shipments to customers', 'customers outside United States', '% of total revenue', 'total revenue']","['Shipments', 0.9298161268234253, 'What is 48% ?', 'Shipments']",Shipments,0.9298161268234252,What is 48% ?,Shipments,Shipments to customers outside the United States
14,"International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively. Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",47,['Concentration percent'],us-gaap_ConcentrationRiskPercentage1,percentItemType,ilmn,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.",47%,PERCENT,"Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively.","['Shipments to customers', 'customers outside United States', '% of total revenue', 'total revenue']","['total revenue', 0.9898989796638489, 'what is total revenue ?', '47%']",total revenue,0.9898989796638488,what is total revenue ?,47%,shipments to customers outside the United States
15,"International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively. Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",56,['Concentration percent'],us-gaap_ConcentrationRiskPercentage1,percentItemType,ilmn,"Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",56%,PERCENT,"Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.","['Customers outside United States', '% of receivable balance', 'receivable balance']","['Customers outside United States', 0.38273659348487854, 'what is Customers outside United States ?', '56% and 53% of our gross trade accounts receivable balance']",Customers outside United States,0.3827365934848785,what is Customers outside United States ?,56% and 53% of our gross trade accounts receivable balance,"Gross trade accounts receivable balance

Entity: 
53%
Phrase: 
Gross trade accounts receivable balance"
16,"International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 49%, 48%, and 47% of total revenue in 2020, 2019, and 2018, respectively. Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",53,['Concentration percent'],us-gaap_ConcentrationRiskPercentage1,percentItemType,ilmn,"Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.",53%,PERCENT,"Customers outside the United States represented 56% and 53% of our gross trade accounts receivable balance as of January 3, 2021 and December 29, 2019, respectively.","['Customers outside United States', '% of receivable balance', 'receivable balance']","['% of receivable balance', 0.7694042325019836, 'what is % of receivable balance ?', '53%']",% of receivable balance,0.7694042325019836,what is % of receivable balance ?,53%,Gross trade accounts receivable balance
17,"We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of January 3, 2021 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S. government sponsored entities, U.S. Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments.",5,['Maximum investment portfolio credit exposure'],ilmn_ConcentrationRiskThreshold,percentItemType,ilmn,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase.",5%,PERCENT,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics , to 30% of the portfolio at the time of purchase.","['amount of credit exposure', 'amount to issuer', '% of portfolio', '% of total issue outstanding size', 'time of purchase', '% of portfolio', 'time of purchase', 'investment policy', 'credit exposure', 'total issue outstanding size', 'industry sector']","['total issue outstanding size', 0.9804848432540894, 'what is total issue outstanding size ?', '5%']",total issue outstanding size,0.9804848432540894,what is total issue outstanding size ?,5%,"Credit exposure to any one issuer

Entity: 
30%
Phrase: 
Any one industry sector"
18,"We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of January 3, 2021 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S. government sponsored entities, U.S. Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments.",5,['Maximum investment portfolio credit exposure'],ilmn_ConcentrationRiskThreshold,percentItemType,ilmn,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase.",5%,PERCENT,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics , to 30% of the portfolio at the time of purchase.","['amount of credit exposure', 'amount to issuer', '% of portfolio', '% of total issue outstanding size', 'time of purchase', '% of portfolio', 'time of purchase', 'investment policy', 'credit exposure', 'total issue outstanding size', 'industry sector']","['total issue outstanding size', 0.9804848432540894, 'what is total issue outstanding size ?', '5%']",total issue outstanding size,0.9804848432540894,what is total issue outstanding size ?,5%,"Credit exposure to any one issuer

Entity: 
30%
Phrase: 
one industry sector"
19,"We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of January 3, 2021 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S. government sponsored entities, U.S. Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments.",30,['Maximum investment portfolio credit exposure'],ilmn_ConcentrationRiskThreshold,percentItemType,ilmn,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase.",30%,PERCENT,"Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics , to 30% of the portfolio at the time of purchase.","['amount of credit exposure', 'amount to issuer', '% of portfolio', '% of total issue outstanding size', 'time of purchase', '% of portfolio', 'time of purchase', 'investment policy', 'credit exposure', 'total issue outstanding size', 'industry sector']","['time of purchase', 0.3762425482273102, 'what is time of purchase ?', '30%']",time of purchase,0.3762425482273102,what is time of purchase ?,30%,One industry sector
20,"Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 60 days from invoice. In instances where right of payment or transfer of title is contingent upon the customer's acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones. Revenue for these agreements is recognized when each distinct performance obligation is satisfied.",60,['Payment period from invoice'],ilmn_RevenueFromContractWithCustomerPaymentTerm,durationItemType,ilmn,Invoicing typically occurs upon shipment and payment is typically due within 60 days from invoice.,60 days,DATE,Invoicing typically occurs upon shipment and payment is typically due within 60 days from invoice.,['days from invoice'],"['Invoicing', 0.22296467423439026, 'What is 60 days ?', 'Invoicing']",Invoicing,0.2229646742343902,What is 60 days ?,Invoicing,Payment from invoice
21,"We lease approximately 2.6 million square feet of office, lab, manufacturing, and distribution facilities under various non cancellable operating lease agreements (real estate leases). Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from approximately 6 months to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms as well as payments for common area maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. We do not have any material financing leases.",1,"['Lessee, operating lease, remaining lease term']",us-gaap_LesseeOperatingLeaseRemainingLeaseTerm,durationItemType,ilmn,"Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised.",approximately 1 to 19 years,DATE,"Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised.","['lease terms of years', 'cancellable periods of leases', 'estate leases', 'lease terms', 'cancellable periods', 'extension options']","['remaining lease terms', 0.420682430267334, 'What is approximately 1 to 19 years ?', 'remaining lease terms']",remaining lease terms,0.420682430267334,What is approximately 1 to 19 years ?,remaining lease terms,remaining lease terms
22,"We lease approximately 2.6 million square feet of office, lab, manufacturing, and distribution facilities under various non cancellable operating lease agreements (real estate leases). Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from approximately 6 months to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms as well as payments for common area maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. We do not have any material financing leases.",19,"['Lessee, operating lease, remaining lease term']",us-gaap_LesseeOperatingLeaseRemainingLeaseTerm,durationItemType,ilmn,"Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised.",approximately 1 to 19 years,DATE,"Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised.","['lease terms of years', 'cancellable periods of leases', 'estate leases', 'lease terms', 'cancellable periods', 'extension options']","['remaining lease terms', 0.420682430267334, 'What is approximately 1 to 19 years ?', 'remaining lease terms']",remaining lease terms,0.420682430267334,What is approximately 1 to 19 years ?,remaining lease terms,remaining lease terms
23,"We lease approximately 2.6 million square feet of office, lab, manufacturing, and distribution facilities under various non cancellable operating lease agreements (real estate leases). Our real estate leases have remaining lease terms of approximately 1 to 19 years, which represent the non cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from approximately 6 months to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms as well as payments for common area maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. We do not have any material financing leases.",20,"['Lessee, operating lease, renewal term']",us-gaap_LesseeOperatingLeaseRenewalTerm,durationItemType,ilmn,"We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from approximately 6 months to 20 years.",approximately 6 months to 20 years,DATE,"We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from approximately 6 months to 20 years.","['extension options', 'lease terms']","['extension options that are not reasonably certain to be exercised from our lease terms', 0.4429660737514496, 'What is approximately 6 months to 20 years ?', 'extension options that are not reasonably certain to be exercised from our lease terms']",extension options that are not reasonably certain to be exercised from our lease terms,0.4429660737514496,What is approximately 6 months to 20 years ?,extension options that are not reasonably certain to be exercised from our lease terms,Extension options lease terms
24,"We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other income, net, along with the re measurement gain or loss on the foreign currency denominated assets or liabilities. As of January 3, 2021, we had foreign exchange forward contracts in place to hedge exposures to monetary assets and liabilities denominated in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound. As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.",405,['Notional amount of outstanding forward contracts'],us-gaap_DerivativeNotionalAmount,monetaryItemType,ilmn,"As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.",$405 million and $252 million,MONEY,"As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.","['total notional amounts of outstanding forward contracts', 'total notional amounts in place', 'total notional amounts for currency purchases', 'total notional amounts', 'outstanding forward contracts', 'currency purchases']","['total notional amounts of outstanding forward contracts', 0.4661957323551178, 'what is total notional amounts of outstanding forward contracts ?', '$405 million and $252 million']",total notional amounts of outstanding forward contracts,0.4661957323551178,what is total notional amounts of outstanding forward contracts ?,$405 million and $252 million,Notional amounts of outstanding forward contracts
25,"We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other income, net, along with the re measurement gain or loss on the foreign currency denominated assets or liabilities. As of January 3, 2021, we had foreign exchange forward contracts in place to hedge exposures to monetary assets and liabilities denominated in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound. As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.",252,['Notional amount of outstanding forward contracts'],us-gaap_DerivativeNotionalAmount,monetaryItemType,ilmn,"As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.",$405 million and $252 million,MONEY,"As of January 3, 2021 and December 29, 2019, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $405 million and $252 million, respectively.","['total notional amounts of outstanding forward contracts', 'total notional amounts in place', 'total notional amounts for currency purchases', 'total notional amounts', 'outstanding forward contracts', 'currency purchases']","['total notional amounts of outstanding forward contracts', 0.4661957323551178, 'what is total notional amounts of outstanding forward contracts ?', '$405 million and $252 million']",total notional amounts of outstanding forward contracts,0.4661957323551178,what is total notional amounts of outstanding forward contracts ?,$405 million and $252 million,Notional amounts of outstanding forward contracts
26,"We also use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms of twelve months or less and are designated as cash flow hedges. Changes in fair value of our cash flow hedges are recorded as a component of accumulated other comprehensive income and are reclassified to revenue in the same period the underlying hedged transactions are recorded. We regularly review the effectiveness of our cash flow hedges and consider them to be ineffective if it becomes probable that the forecasted transactions will not occur in the identified period. Changes in fair value of the ineffective portions of our cash flow hedges, if any, will be recognized in other income, net. As of January 3, 2021, we had foreign currency forward contracts in place to hedge exposures associated with forecasted revenue transactions denominated in the euro, Japanese yen, Australian dollar, and Canadian dollar. As of January 3, 2021, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases was $305 million. There were no outstanding cash flow hedge contracts in place as of December 29, 2019.",305,['Notional amount of outstanding forward contracts'],us-gaap_DerivativeNotionalAmount,monetaryItemType,ilmn,"As of January 3, 2021, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases was $305 million.",$305 million,MONEY,"As of January 3, 2021, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases was $305 million.","['total notional amounts of outstanding flow hedge contracts', 'total notional amounts in place', 'total notional amounts for currency purchases', 'total notional amounts', 'outstanding flow hedge contracts', 'currency purchases']","['total notional amounts of outstanding flow hedge contracts', 0.9564887285232544, 'what is total notional amounts of outstanding flow hedge contracts ?', '$305 million']",total notional amounts of outstanding flow hedge contracts,0.9564887285232544,what is total notional amounts of outstanding flow hedge contracts ?,$305 million,Notional amounts of cash flow hedge contracts
27,"We generally provide a one year warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from six to twelve months after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.",one year,['Warranty period'],ilmn_StandardProductWarrantyDescriptionTerm,durationItemType,ilmn,We generally provide a one year warranty on instruments.,one year,DATE,We generally provide a one year warranty on instruments.,"['year warranty on instruments', 'year warranty']","['warranty', 0.703992486000061, 'What is one year ?', 'warranty']",warranty,0.703992486000061,What is one year ?,warranty,instrument warranty
28,"volatility is determined by equally weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term, adjusted for the impact of unusual fluctuations and other relevant factors. The implied volatility is calculated from the implied market volatility of exchange traded call options on our common stock. The expected term is based on historical forfeiture experience and the terms and conditions of the ESPP. The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share based awards.",0,"['Expected dividend yield', 'Expected dividends']",us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,percentItemType,ilmn,The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends.,0%,PERCENT,The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends.,"['dividend yield', 'cash dividends', 'common stock', 'such cash dividends']","['dividend yield', 0.9791094660758972, 'what is dividend yield ?', '0%']",dividend yield,0.9791094660758972,what is dividend yield ?,0%,Dividend yield
29,"Advertising costs are expensed as incurred. Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",28,['Advertising costs'],us-gaap_AdvertisingExpense,monetaryItemType,ilmn,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",$28 million,MONEY,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",['Advertising costs'],"['Advertising costs', 0.9683500528335571, 'What is $28 million ?', 'Advertising costs']",Advertising costs,0.9683500528335572,What is $28 million ?,Advertising costs,Advertising costs
30,"Advertising costs are expensed as incurred. Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",28,['Advertising costs'],us-gaap_AdvertisingExpense,monetaryItemType,ilmn,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",$28 million,MONEY,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",['Advertising costs'],"['Advertising costs', 0.9683500528335571, 'What is $28 million ?', 'Advertising costs']",Advertising costs,0.9683500528335572,What is $28 million ?,Advertising costs,Advertising costs in 2020
31,"Advertising costs are expensed as incurred. Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",38,['Advertising costs'],us-gaap_AdvertisingExpense,monetaryItemType,ilmn,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",$38 million,MONEY,"Advertising costs were $28 million, $28 million, and $38 million in 2020, 2019, and 2018, respectively.",['Advertising costs'],"['Advertising costs', 0.3493286073207855, 'What is $38 million ?', 'Advertising costs']",Advertising costs,0.3493286073207855,What is $38 million ?,Advertising costs,Advertising costs in 2018
32,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","1,655","['Revenue', 'Total revenue']",us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax,monetaryItemType,ilmn,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","$1,655 million",MONEY,"1 Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","['Revenue for Americas region', 'States revenue', 'Americas region', 'States revenue']","['States revenue', 0.9316387176513672, 'what is States revenue ?', '$1,655 million']",States revenue,0.9316387176513672,what is States revenue ?,"$1,655 million",United States revenue
33,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","1,859","['Revenue', 'Total revenue']",us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax,monetaryItemType,ilmn,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","$1,859 million",MONEY,"1 Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","['Revenue for Americas region', 'States revenue', 'Americas region', 'States revenue']","['', 0, '', '']",,0.0,,,United States revenue
34,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","1,779","['Revenue', 'Total revenue']",us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax,monetaryItemType,ilmn,"(1) Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","$1,779 million",MONEY,"1 Revenue for the Americas region included United States revenue of $1,655 million, $1,859 million, and $1,779 million in 2020, 2019, and 2018, respectively.","['Revenue for Americas region', 'States revenue', 'Americas region', 'States revenue']","['', 0, '', '']",,0.0,,,United States revenue
35,"We regularly enter into contracts with multiple performance obligations. Most performance obligations are generally satisfied within a short time frame, approximately three to six months, after the contract execution date. As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",816,['Remaining performance obligation'],us-gaap_RevenueRemainingPerformanceObligation,monetaryItemType,ilmn,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",$816 million,MONEY,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.","['aggregate amount of transaction price', '% in following months', 'transaction price', 'performance obligations']","['aggregate amount of transaction price', 0.9771041870117188, 'what is aggregate amount of transaction price ?', '$816 million']",aggregate amount of transaction price,0.9771041870117188,what is aggregate amount of transaction price ?,$816 million,Transaction price allocated to remaining performance obligations
36,"We regularly enter into contracts with multiple performance obligations. Most performance obligations are generally satisfied within a short time frame, approximately three to six months, after the contract execution date. As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",90,['Percent of remaining performance obligation'],us-gaap_RevenueRemainingPerformanceObligationPercentage,percentItemType,ilmn,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",approximately 90%,PERCENT,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.","['aggregate amount of transaction price', '% in following months', 'transaction price', 'performance obligations']","['revenue', 0.88276606798172, 'What is approximately 90% ?', 'revenue']",revenue,0.88276606798172,What is approximately 90% ?,revenue,the aggregate amount of the transaction price allocated to remaining performance obligations
37,"We regularly enter into contracts with multiple performance obligations. Most performance obligations are generally satisfied within a short time frame, approximately three to six months, after the contract execution date. As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",7,['Percent of remaining performance obligation'],us-gaap_RevenueRemainingPerformanceObligationPercentage,percentItemType,ilmn,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",approximately 7%,PERCENT,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.","['aggregate amount of transaction price', '% in following months', 'transaction price', 'performance obligations']","['revenue', 0.5124980211257935, 'What is approximately 7% ?', 'revenue']",revenue,0.5124980211257935,What is approximately 7% ?,revenue,the following twelve months
38,"We regularly enter into contracts with multiple performance obligations. Most performance obligations are generally satisfied within a short time frame, approximately three to six months, after the contract execution date. As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",twelve months,"['Revenue, remaining performance obligation, expected timing of satisfaction, period']",us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1,durationItemType,ilmn,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",twelve months,DATE,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.","['aggregate amount of transaction price', '% in following months', 'transaction price', 'performance obligations']","['7%', 0.6625921130180359, 'What is twelve months ?', '7%']",7%,0.6625921130180359,What is twelve months ?,7%,the remainder
39,"We regularly enter into contracts with multiple performance obligations. Most performance obligations are generally satisfied within a short time frame, approximately three to six months, after the contract execution date. As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",twelve months,"['Revenue, remaining performance obligation, expected timing of satisfaction, period']",us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1,durationItemType,ilmn,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.",twelve months,DATE,"As of January 3, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $816 million, of which approximately 90% is expected to be converted to revenue through 2021, approximately 7% in the following twelve months, and the remainder thereafter.","['aggregate amount of transaction price', '% in following months', 'transaction price', 'performance obligations']","['7%', 0.6625921130180359, 'What is twelve months ?', '7%']",7%,0.6625921130180359,What is twelve months ?,7%,the remainder
40,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities. Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",230,['Contract liability'],us-gaap_ContractWithCustomerLiability,monetaryItemType,ilmn,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.",$230 million,MONEY,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.","['Contract liabilities', 'term portions', 'term portions', 'Contract liabilities', 'deferred revenue', 'term portions', 'term portions', 'other term liabilities']","['Contract liabilities', 0.6959407329559326, 'What is $230 million ?', 'Contract liabilities']",Contract liabilities,0.6959407329559326,What is $230 million ?,Contract liabilities,"Contract liabilities as of January 3, 2021"
41,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities. Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",209,['Contract liability'],us-gaap_ContractWithCustomerLiability,monetaryItemType,ilmn,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.",$209 million,MONEY,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.","['Contract liabilities', 'term portions', 'term portions', 'Contract liabilities', 'deferred revenue', 'term portions', 'term portions', 'other term liabilities']","['Contract liabilities', 0.1639595329761505, 'What is $209 million ?', 'Contract liabilities']",Contract liabilities,0.1639595329761505,What is $209 million ?,Contract liabilities,"Contract liabilities as of December 29, 2019"
42,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities. Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",186,"['Contract liabilities, current portion', 'Contract liabilities, current portion']",us-gaap_ContractWithCustomerLiabilityCurrent,monetaryItemType,ilmn,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.",$186 million,MONEY,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.","['Contract liabilities', 'term portions', 'term portions', 'Contract liabilities', 'deferred revenue', 'term portions', 'term portions', 'other term liabilities']","['term portions', 0.633886992931366, 'what is term portions ?', '$186 million and $167 million']",term portions,0.633886992931366,what is term portions ?,$186 million and $167 million,Short term portion of contract liabilities
43,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities. Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",167,"['Contract liabilities, current portion', 'Contract liabilities, current portion']",us-gaap_ContractWithCustomerLiabilityCurrent,monetaryItemType,ilmn,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.",$167 million,MONEY,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities.","['Contract liabilities', 'term portions', 'term portions', 'Contract liabilities', 'deferred revenue', 'term portions', 'term portions', 'other term liabilities']","['term portions', 0.633886992931366, 'what is term portions ?', '$186 million and $167 million']",term portions,0.633886992931366,what is term portions ?,$186 million and $167 million,Short-term portion of contract liabilities
44,"Contract liabilities, which consist of deferred revenue and customer deposits, as of January 3, 2021 and December 29, 2019 were $230 million and $209 million, respectively, of which the short term portions of $186 million and $167 million, respectively, were recorded in accrued liabilities and the remaining long term portions were recorded in other long term liabilities. Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",156,"['Revenue recognized, previously deferred']",us-gaap_ContractWithCustomerLiabilityRevenueRecognized,monetaryItemType,ilmn,"Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",$156 million,MONEY,"Revenue recorded in 2020 included $156 million of previously deferred revenue that was included in contract liabilities as of December 29, 2019.",['contract liabilities'],"['contract liabilities', 0.22828294336795807, 'what is contract liabilities ?', '$156 million of previously deferred revenue']",contract liabilities,0.228282943367958,what is contract liabilities ?,$156 million of previously deferred revenue,Previously deferred revenue
45,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively. Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",376,['Marketable equity securities'],us-gaap_EquitySecuritiesFvNi,monetaryItemType,ilmn,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively.",$376 million,MONEY,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively.","['fair value of marketable equity securities', 'fair value', 'marketable equity securities', 'term investments']","['marketable equity securities', 0.33837786316871643, 'What is $376 million ?', 'marketable equity securities']",marketable equity securities,0.3383778631687164,What is $376 million ?,marketable equity securities,The fair value of our marketable equity securities
46,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively. Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",106,['Marketable equity securities'],us-gaap_EquitySecuritiesFvNi,monetaryItemType,ilmn,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively.",$106 million,MONEY,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively.","['fair value of marketable equity securities', 'fair value', 'marketable equity securities', 'term investments']","['fair value of marketable equity securities', 0.43133488297462463, 'what is fair value of marketable equity securities ?', '$106 million']",fair value of marketable equity securities,0.4313348829746246,what is fair value of marketable equity securities ?,$106 million,Short term investments
47,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively. Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",270,['Marketable equity securities unrealized losses and gains'],us-gaap_EquitySecuritiesFvNiUnrealizedGain,monetaryItemType,ilmn,"Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",$270 million,MONEY,"Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.","['Total unrealized gains on marketable equity securities', 'Total unrealized gains', 'marketable equity securities', 'other income']","['Total unrealized gains on marketable equity securities', 0.6042923331260681, 'what is Total unrealized gains on marketable equity securities ?', '$270 million']",Total unrealized gains on marketable equity securities,0.6042923331260681,what is Total unrealized gains on marketable equity securities ?,$270 million,Total unrealized gains on marketable equity securities
48,"As of January 3, 2021 and December 29, 2019, the fair value of our marketable equity securities, included in short term investments, totaled $376 million and $106 million, respectively. Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",53,['Marketable equity securities unrealized losses and gains'],us-gaap_EquitySecuritiesFvNiUnrealizedGain,monetaryItemType,ilmn,"Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.",$53 million,MONEY,"Total unrealized gains on our marketable equity securities, included in other income, net, were $270 million, $53 million, and $21 million in 2020, 2019, and 2018, respectively.","['Total unrealized gains on marketable equity securities', 'Total unrealized gains', 'marketable equity securities', 'other income']","['Total unrealized gains on our marketable equity securities', 0.42190930247306824, 'What is $53 million ?', 'Total unrealized gains on our marketable equity securities']",Total unrealized gains on our marketable equity securities,0.4219093024730682,What is $53 million ?,Total unrealized gains on our marketable equity securities,unrealized gains on marketable equity securities
49,"As of January 3, 2021 and December 29, 2019, the aggregate carrying amounts of our non marketable equity securities without readily determinable fair values, included in other assets, were $314 million and $220 million, respectively.",314,"['Strategic equity investments, without readily determinable fair values']",us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount,monetaryItemType,ilmn,"As of January 3, 2021 and December 29, 2019, the aggregate carrying amounts of our non marketable equity securities without readily determinable fair values, included in other assets, were $314 million and $220 million, respectively.",$314 million,MONEY,"As of January 3, 2021 and December 29, 2019, the aggregate carrying amounts of our non marketable equity securities without readily determinable fair values, included in other assets, were $314 million and $220 million, respectively.","['carrying amounts of non marketable equity securities', 'carrying amounts without determinable fair values', 'non marketable equity securities', 'determinable fair values', 'other assets']","['', 0, '', '']",,0.0,,,Non marketable equity securities without readily determinable fair values
